4//SEC Filing
OBALON THERAPEUTICS INC 4
Accession 0001214659-17-002940
$HINDCIK 0001427570operating
Filed
May 1, 8:00 PM ET
Accepted
May 2, 6:52 PM ET
Size
4.8 KB
Accession
0001214659-17-002940
Insider Transaction Report
Form 4
Brister Mark
VP of Research and Development
Transactions
- Award
Common Stock
2017-04-30$9.03/sh+1,550$13,996→ 162,010 total
Footnotes (1)
- [F1]These shares were acquired under the Obalon Therapeutics, Inc. 2016 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
OBALON THERAPEUTICS INC
CIK 0001427570
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001427570
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 6:52 PM ET
- Size
- 4.8 KB